LONDON--Pharmaceutical company PureTech Health PLC (PRTC.LN) said Thursday that it has appointed Atul Pande as chief medical officer of the company.

Mr. Pande, who formerly was a senior adviser and head of neuroscience division at GlaxoSmithKline PLC (GSK.LN), will oversee all clinical operations, the company said.

Shares of PureTech at 0905 GMT trading 1.1% higher at 117 pence.

Write to Tapan Panchal at tapan.panchal@wsj.com

(END) Dow Jones Newswires

February 23, 2017 04:22 ET (09:22 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Puretech Health Charts.
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Puretech Health Charts.